In a statement issued to media outlets after The Wall Street Journal reported that Health Secretary Robert F. Kennedy Jr. plans to link pregnant women’s use of the pain killer Tylenol to autism, Kenvue (KVUE) said: “Nothing is more important to us than the health and safety of the people who use our products. We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.” Kenvue adds that it advises expecting mothers to speak to healthcare professionals before taking any over-the-counter medications, including acetaminophen.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- RFK Jr. to claim autism link to Tylenol use in pregnancy, WSJ reports
- Kenvue drops 9% to $18.74 after WSJ report
- Kenvue sinks after WSJ says RFK to link autism to Tylenol use
- Kenvue Inc put volume heavy and directionally bearish
- Third Point boosts position in Nvidia, takes new stakes in Mr Cooper, Meta